These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 9312132)

  • 41. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
    Baum PR; Gayle RB; Ramsdell F; Srinivasan S; Sorensen RA; Watson ML; Seldin MF; Baker E; Sutherland GR; Clifford KN
    EMBO J; 1994 Sep; 13(17):3992-4001. PubMed ID: 8076595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand.
    Min JK; Kim YM; Kim YM; Kim EC; Gho YS; Kang IJ; Lee SY; Kong YY; Kwon YG
    J Biol Chem; 2003 Oct; 278(41):39548-57. PubMed ID: 12893832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related.
    Shi CS; Leonardi A; Kyriakis J; Siebenlist U; Kehrl JH
    J Immunol; 1999 Sep; 163(6):3279-85. PubMed ID: 10477597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL; Krebs DL; Gold MR
    J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
    Reinhard C; Shamoon B; Shyamala V; Williams LT
    EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
    J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton.
    Fu CA; Shen M; Huang BC; Lasaga J; Payan DG; Luo Y
    J Biol Chem; 1999 Oct; 274(43):30729-37. PubMed ID: 10521462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
    Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
    J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation.
    Nagai M; Kyakumoto S; Sato N
    Biochem Biophys Res Commun; 2000 Mar; 269(2):532-6. PubMed ID: 10708588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways.
    Mühlenbeck F; Haas E; Schwenzer R; Schubert G; Grell M; Smith C; Scheurich P; Wajant H
    J Biol Chem; 1998 Dec; 273(49):33091-8. PubMed ID: 9830064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.
    Marsters SA; Sheridan JP; Donahue CJ; Pitti RM; Gray CL; Goddard AD; Bauer KD; Ashkenazi A
    Curr Biol; 1996 Dec; 6(12):1669-76. PubMed ID: 8994832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of two receptors for TRAIL.
    Schneider P; Bodmer JL; Thome M; Hofmann K; Holler N; Tschopp J
    FEBS Lett; 1997 Oct; 416(3):329-34. PubMed ID: 9373179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase.
    Sah NK; Munshi A; Kurland JF; McDonnell TJ; Su B; Meyn RE
    J Biol Chem; 2003 Jun; 278(23):20593-602. PubMed ID: 12663665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction.
    Cremer I; Dieu-Nosjean MC; Maréchal S; Dezutter-Dambuyant C; Goddard S; Adams D; Winter N; Menetrier-Caux C; Sautès-Fridman C; Fridman WH; Mueller CG
    Blood; 2002 Nov; 100(10):3646-55. PubMed ID: 12393586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor.
    Pan G; Bauer JH; Haridas V; Wang S; Liu D; Yu G; Vincenz C; Aggarwal BB; Ni J; Dixit VM
    FEBS Lett; 1998 Jul; 431(3):351-6. PubMed ID: 9714541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
    Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
    Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
    J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.